Health Care Research and Customer Insights

Our Objective Insights. Your Strategic Advantage.

Darwin Research Group delivers strategic intelligence and deep executive insights that guide health care leaders to make confident decisions. Our expert knowledge of the ever-evolving health care landscape gives you the perspective you need to stay ahead.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?

Eli Lilly

artificial intelligence

April 20, 2026

Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?

Gilead Sciences

acquisition

April 13, 2026

Darwin's Our Take: Gilead announces third acquisition of 2026

Darwin's Our Take: The uptick in Big Pharma M&A activity continues

Eli Lilly

Novo Nordisk

April 6, 2026

Darwin's Our Take: The uptick in Big Pharma M&A activity continues

Providing insights for the most prominent leaders in health care.

Our Services

We’re here to serve you.

We provide the intelligence and insight health care leaders need to move beyond transactions and build a more connected, strategic approach to growth.

Explore all Services

Consulting & Strategic Counsel

We work with CEOs and other senior executives and tailor strategic intelligence services to the specific needs of the highest levels in an organization. Darwin CEO John Marchica leads this effort, providing his analysis and guidance directly to the client.

Learn More

Customer Intelligence, Data, & Profiles

We develop each health system profile profile with rigor and strategic intent, and complete it with rich, actionable insights across all facets of the organization.

Learn More

Inside Access To Research & Data

When our clients need to sharpen their business, marketing, market access, and sales strategies, they rely on the customer profiles we develop to inform and enhance their decision making, using them over and over again as a vital “go to” resource.

Learn More

Are you getting the right information you need to make decisions?

Featured Insights from Darwin

Our Take Newsletter

Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?

Learn More

Our Take Newsletter

Darwin's Our Take: Gilead announces third acquisition of 2026

Learn More

Our Take Newsletter

Darwin's Our Take: The uptick in Big Pharma M&A activity continues

Learn More

podcast

April 17, 2026

Podcast 204: What’s Really Holding Back Value-Based Care? w/ David Snow, Chairman & CEO, Cedar Gate Technologies

Listen in

podcast

April 3, 2026

Podcast 203: Rebuilding Pediatric Care From the Ground Up w/ Danish Qureshi, Founder & CEO, Zarminali Pediatrics

Listen in

podcast

March 20, 2026

Podcast 202: Lessons From Leading a Safety Net Hospital w/ Tesa Anewishki, President & CEO, Loretto Hospital

Listen in

podcast

March 6, 2026

Podcast 201: How the VA Proved The Pharma Model Wrong w/ Dr. Eric Scott, U.S. Dept. of Veteran Affairs

Listen in

podcast

February 20, 2026

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health

Listen in

Explore All Content

Stay Aware. Stay Informed.

Subscribe to Our Take

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Explore Content

Our Objective Insights. Your Strategic Advantage.

Darwin Research Group delivers strategic intelligence and deep executive insights that guide health care leaders to make confident decisions. Our expert knowledge of the ever-evolving health care landscape gives you the perspective you need to stay ahead.

Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?

Darwin's Our Take: Gilead announces third acquisition of 2026

Darwin's Our Take: The uptick in Big Pharma M&A activity continues

Providing insights for the most prominent leaders in health care.

We’re here to serve you.

Consulting & Strategic Counsel

Customer Intelligence, Data, & Profiles

Inside Access To Research & Data

Are you getting the right information you need to make decisions?

Featured Insights from Darwin

Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?

Darwin's Our Take: Gilead announces third acquisition of 2026

Darwin's Our Take: The uptick in Big Pharma M&A activity continues

Podcast 204: What’s Really Holding Back Value-Based Care? w/ David Snow, Chairman & CEO, Cedar Gate Technologies

Podcast 203: Rebuilding Pediatric Care From the Ground Up w/ Danish Qureshi, Founder & CEO, Zarminali Pediatrics

Podcast 202: Lessons From Leading a Safety Net Hospital w/ Tesa Anewishki, President & CEO, Loretto Hospital

Podcast 201: How the VA Proved The Pharma Model Wrong w/ Dr. Eric Scott, U.S. Dept. of Veteran Affairs

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health

Subscribe to Our Take

Podcast 204: What’s Really Holding Back Value-Based Care? w/ David Snow, Chairman & CEO, Cedar Gate Technologies

Podcast 203: Rebuilding Pediatric Care From the Ground Up w/ Danish Qureshi, Founder & CEO, Zarminali Pediatrics

Podcast 202: Lessons From Leading a Safety Net Hospital w/ Tesa Anewishki, President & CEO, Loretto Hospital

Services

Company